{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:04Z","timestamp":1791235384795,"version":"4.1.0"},"reference-count":144,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["101550"],"award-info":[{"award-number":["101550"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["wellcomeopenresearch.org"],"crossmark-restriction":false},"short-container-title":["Wellcome Open Res"],"abstract":"<ns3:p>\n                    <ns3:bold>Background<\/ns3:bold>\n                    : Animal models of Duchenne muscular dystrophy (DMD) are essential to study disease progression and assess efficacy of therapeutic intervention, however dystrophic mice fail to display a clinically relevant phenotype, limiting translational utility. Dystrophin-deficient dogs exhibit disease similar to humans, making them increasingly important for late-stage preclinical evaluation of candidate therapeutics. The DE50-MD canine model of DMD carries a mutation within a human \u2018hotspot\u2019 region of the dystrophin gene, amenable to exon-skipping and gene editing strategies. As part of a large natural history study of disease progression, we have characterised the DE50-MD skeletal muscle phenotype to identify parameters that could serve as efficacy biomarkers in future preclinical trials.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Methods<\/ns3:bold>\n                    :\n                    <ns3:italic>Vastus lateralis<\/ns3:italic>\n                    muscles were biopsied from a large cohort of DE50-MD dogs and healthy male littermates at 3-monthly intervals (3-18 months) for longitudinal analysis, with multiple muscles collected post-mortem to evaluate body-wide changes. Pathology was characterised quantitatively using histology and measurement of gene expression to determine statistical power and sample sizes appropriate for future work.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Results<\/ns3:bold>\n                    : DE50-MD skeletal muscle exhibits widespread degeneration\/regeneration, fibrosis, atrophy and inflammation. Degenerative\/inflammatory changes peak during the first year of life, while fibrotic remodelling appears more gradual. Pathology is similar in most skeletal muscles, but in the diaphragm, fibrosis is more prominent, associated with fibre splitting and pathological hypertrophy. Picrosirius red and acid phosphatase staining represent useful quantitative histological biomarkers for fibrosis and inflammation respectively, while qPCR can be used to measure regeneration (\n                    <ns3:italic>MYH3<\/ns3:italic>\n                    ,\n                    <ns3:italic>MYH8<\/ns3:italic>\n                    ), fibrosis (\n                    <ns3:italic>COL1A1<\/ns3:italic>\n                    ), inflammation (\n                    <ns3:italic>SPP1<\/ns3:italic>\n                    ), and stability of DE50-MD dp427 transcripts.\n                  <\/ns3:p>\n                  <ns3:p>\n                    <ns3:bold>Conclusion<\/ns3:bold>\n                    : The DE50-MD dog is a valuable model of DMD, with pathological features similar to young, ambulant human patients. Sample size and power calculations show that our panel of muscle biomarkers are of strong pre-clinical value, able to detect therapeutic improvements of even 25%, using trials with only six animals per group.\n                  <\/ns3:p>","DOI":"10.12688\/wellcomeopenres.18251.1","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T10:12:33Z","timestamp":1663927953000},"page":"238","update-policy":"https:\/\/doi.org\/10.12688\/wellcomeopenres.crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy"],"prefix":"10.12688","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2283-2118","authenticated-orcid":false,"given":"John C.W.","family":"Hildyard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1614-504X","authenticated-orcid":false,"given":"Dominique O.","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9418-0708","authenticated-orcid":false,"given":"Rachel C.M.","family":"Harron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-2489","authenticated-orcid":false,"given":"Faye","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-6547","authenticated-orcid":false,"given":"Claire","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Taylor-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1425-6344","authenticated-orcid":false,"given":"Dominic J.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4344-6438","authenticated-orcid":false,"given":"Richard J.","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"304-13","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy.","volume":"71","author":"J Mendell","year":"2012","journal-title":"Ann Neurol."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"731-740","DOI":"10.1016\/s1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes.","volume":"2","author":"F Muntoni","year":"2003","journal-title":"Lancet Neurol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1038\/s41598-019-39532-4","article-title":"Regulation of the dystrophin-associated glycoprotein complex composition by the metabolic properties of muscle fibres.","volume":"9","author":"S Omairi","year":"2019","journal-title":"Sci Rep."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"210797","DOI":"10.1155\/2011\/210797","article-title":"The dystrophin-glycoprotein complex in the prevention of muscle damage.","volume":"2011","author":"J Gumerson","year":"2011","journal-title":"J Biomed Biotechnol."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy.","volume":"7","author":"D Duan","year":"2021","journal-title":"Nat Rev Dis Primers."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"961-976","DOI":"10.1177\/0192623317734823","article-title":"Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.","volume":"45","author":"K Wilson","year":"2017","journal-title":"Toxicol Pathol."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-021-01758-9","article-title":"Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?","volume":"16","author":"S Kourakis","year":"2021","journal-title":"Orphanet J Rare Dis."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"2337-2356","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.","volume":"26","author":"D Duan","year":"2018","journal-title":"Mol Ther."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"828-34","DOI":"10.1038\/nm1085","article-title":"Systemic delivery of genes to striated muscles using adeno-associated viral vectors.","volume":"10","author":"P Gregorevic","year":"2004","journal-title":"Nat Med."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"623-635","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of Novel Micro-dystrophins with Enhanced Functionality.","volume":"27","author":"J Ramos","year":"2019","journal-title":"Mol Ther."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"3179-3191","DOI":"10.1016\/j.ymthe.2021.04.002","article-title":"CRISPR technologies for the treatment of Duchenne muscular dystrophy.","volume":"29","author":"E Choi","year":"2021","journal-title":"Mol Ther."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"e2004840117","DOI":"10.1073\/pnas.2004840117","article-title":"Toward the correction of muscular dystrophy by gene editing.","volume":"118","author":"E Olson","year":"2021","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"542-548","DOI":"10.1038\/s41434-021-00222-4","article-title":"Genome editing for Duchenne muscular dystrophy: a glimpse of the future?","volume":"28","author":"C Kupatt","year":"2021","journal-title":"Gene Ther."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"251-259","DOI":"10.1089\/nat.2017.0682","article-title":"Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues.","volume":"27","author":"A Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"1-3","DOI":"10.1089\/nat.2016.0657","article-title":"FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga.","volume":"27","author":"A Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"257-71","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.","volume":"79","author":"J Mendell","year":"2016","journal-title":"Ann Neurol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"637-47","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy.","volume":"74","author":"J Mendell","year":"2013","journal-title":"Ann Neurol."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"293-9","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.","volume":"30","author":"A Aartsma-Rus","year":"2009","journal-title":"Hum Mutat."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"907-14","DOI":"10.1093\/hmg\/ddg100","article-title":"Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.","volume":"12","author":"A Aartsma-Rus","year":"2003","journal-title":"Hum Mol Genet."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"400-3","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.","volume":"351","author":"C Long","year":"2016","journal-title":"Science."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"1184-1188","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA.","volume":"345","author":"C Long","year":"2014","journal-title":"Science."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1578-80","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.","volume":"244","author":"P Sicinski","year":"1989","journal-title":"Science."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"91-5","DOI":"10.1007\/BF00687043","article-title":"Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse.","volume":"69","author":"Y Tanabe","year":"1986","journal-title":"Acta Neuropathol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"195-213","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.","volume":"8","author":"J McGreevy","year":"2015","journal-title":"Dis Model Mech."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"97-105","DOI":"10.1016\/0022-510x(94)00276-t","article-title":"mdx mice show progressive weakness and muscle deterioration with age.","volume":"129","author":"C Pastoret","year":"1995","journal-title":"J Neurol Sci."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13395-017-0124-z","article-title":"The golden retriever model of Duchenne muscular dystrophy.","volume":"7","author":"J Kornegay","year":"2017","journal-title":"Skelet Muscle."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"57-69","DOI":"10.1089\/humc.2015.006","article-title":"Duchenne muscular dystrophy gene therapy in the canine model.","volume":"26","author":"D Duan","year":"2015","journal-title":"Hum Gene Ther Clin Dev."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"e8647","DOI":"10.1371\/journal.pone.0008647","article-title":"A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.","volume":"5","author":"G Walmsley","year":"2010","journal-title":"PLoS One."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S0960-8966(18)30342-0","article-title":"Characterising the skeletal muscle histological phenotype of the DeltaE50-MD dog, a preclinical model of Duchenne muscular dystrophy.","volume":"28","author":"J Hildyard","year":"2018","journal-title":"Neuromuscular Disorders."},{"key":"ref-30","first-page":"835-847","article-title":"Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.","volume":"45","author":"J Den Dunnen","year":"1989","journal-title":"Am J Hum Genet."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"421-4","DOI":"10.1006\/geno.1997.4911","article-title":"Exon-intron organization of the human dystrophin gene.","volume":"45","author":"C Nobile","year":"1997","journal-title":"Genomics."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"599-603","DOI":"10.1093\/hmg\/1.8.599","article-title":"Two hot spots of recombination in the DMD gene correlate with the deletion prone regions.","volume":"1","author":"C Oudet","year":"1992","journal-title":"Hum Mol Genet."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jpm8040041","article-title":"Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges.","volume":"8","author":"Y Echigoya","year":"2018","journal-title":"J Pers Med."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"86-91","DOI":"10.1126\/science.aau1549","article-title":"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.","volume":"362","author":"L Amoasii","year":"2018","journal-title":"Science."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.12688\/wellcomeopenres.17398.2","article-title":"Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy [version 2; peer review: 2 approved].","volume":"6","author":"D Riddell","year":"2021","journal-title":"Wellcome Open Res."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"736-751","DOI":"10.1016\/j.nmd.2021.05.010","article-title":"Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy.","volume":"31","author":"N Hornby","year":"2021","journal-title":"Neuromuscul Disord."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"dmm049291","DOI":"10.1242\/dmm.049291","article-title":"Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy.","volume":"15","author":"A Crawford","year":"2022","journal-title":"Dis Model Mech."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"609-31","DOI":"10.1016\/j.pmr.2012.06.006","article-title":"Muscle biopsy evaluation in neuromuscular disorders.","volume":"23","author":"N Joyce","year":"2012","journal-title":"Phys Med Rehabil Clin N Am."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"15000-5","DOI":"10.1073\/pnas.192571199","article-title":"Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle.","volume":"99","author":"J Haslett","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13395-015-0046-6","article-title":"Developmental myosins: expression patterns and functional significance.","volume":"5","author":"S Schiaffino","year":"2015","journal-title":"Skelet Muscle."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.12688\/wellcomeopenres.15762.2","article-title":"Single-transcript multiplex in situ hybridisation reveals unique patterns of dystrophin isoform expression in the developing mammalian embryo [version 2; peer review: 2 approved].","volume":"5","author":"J Hildyard","year":"2020","journal-title":"Wellcome Open Res."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"1719-1727","DOI":"10.1111\/jvim.15543","article-title":"Clinical characteristics, breed differences, and quality of life in North American dogs with acute steroid-responsive meningitis-arteritis.","volume":"33","author":"J Lau","year":"2019","journal-title":"J Vet Intern Med."},{"key":"ref-43","article-title":"Skeletal muscle phenotype of the DE50-MD dog: extended data.","author":"J Hildyard","year":"2022","journal-title":"Figshare."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"e91221","DOI":"10.1371\/journal.pone.0091221","article-title":"Poloxamer [corrected] 188 has a deleterious effect on dystrophic skeletal muscle function.","volume":"9","author":"R Terry","year":"2014","journal-title":"PLoS One."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"343-54","DOI":"10.1007\/s13402-011-0035-7","article-title":"Rapid quantification of myocardial fibrosis: a new macro-based automated analysis.","volume":"34","author":"A Hadi","year":"2011","journal-title":"Cell Oncol (Dordr)."},{"key":"ref-46","doi-asserted-by":"publisher","DOI":"10.1101\/2022.08.02.502489","article-title":"Rapid histological quantification of muscle fibrosis and lysosomal activity using the HSB colour space.","author":"J Hildyard","year":"2022","journal-title":"BioRxiv."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"e0239467","DOI":"10.1371\/journal.pone.0239467","article-title":"Multiplex in situ hybridization within a single transcript: RNAscope reveals dystrophin mRNA dynamics.","volume":"15","author":"J Hildyard","year":"2020","journal-title":"PLoS One."},{"key":"ref-48","first-page":"2022","article-title":"Skeletal muscle phenotype of the DE50-MD dog: picrosirius red","author":"J Hildyard","journal-title":"Figshare"},{"key":"ref-49","article-title":"Skeletal muscle phenotype of the DE50-MD dog: Acid phosphatase","author":"J Hildyard","year":"2022","journal-title":"Figshare"},{"key":"ref-50","article-title":"Skeletal muscle phenotype of the DE50-MD dog: H&E","author":"J Hildyard","year":"2022","journal-title":"Figshare"},{"key":"ref-51","article-title":"Skeletal muscle phenotype of the DE50-MD dog: fibre profiles and revertants.","author":"J Hildyard","year":"2022","journal-title":"Figshare."},{"key":"ref-52","article-title":"Skeletal muscle phenotype of the DE50-MD dog: immunofluorescence","author":"J Hildyard","year":"2022","journal-title":"Figshare"},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate.","volume":"7","author":"H Motulsky","year":"2006","journal-title":"BMC Bioinformatics."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"e0211384","DOI":"10.1371\/journal.pone.0211384","article-title":"Identification of qPCR reference genes suitable for normalizing gene expression in the mdx mouse model of Duchenne muscular dystrophy.","volume":"14","author":"J Hildyard","year":"2019","journal-title":"PLoS One."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"177-191","DOI":"10.3233\/JND-170267","article-title":"Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy.","volume":"5","author":"J Hildyard","year":"2018","journal-title":"J Neuromuscul Dis."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.12688\/wellcomeopenres.16972.1","article-title":"Identification of qPCR reference genes suitable for normalising gene expression in the developing mouse embryo [version 1; peer review: 1 approved, 2 approved with reservations].","volume":"6","author":"J Hildyard","year":"2021","journal-title":"Wellcome Open Res."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"23-39","DOI":"10.1677\/jme.0.0290023","article-title":"Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.","volume":"29","author":"S Bustin","year":"2002","journal-title":"J Mol Endocrinol."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"611-22","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.","volume":"55","author":"S Bustin","year":"2009","journal-title":"Clin Chem."},{"key":"ref-59","article-title":"Skeletal muscle phenotype of the DE50-MD dog: qPCR data","author":"J Hildyard","year":"2022","journal-title":"Figshare"},{"key":"ref-60","article-title":"Skeletal muscle phenotype of the DE50-MD dog: PRISM data","author":"J Hildyard","year":"2022","journal-title":"Figshare"},{"key":"ref-61","article-title":"Skeletal muscle phenotype of the DE50-MD dog: SPSS data","author":"J Hildyard","year":"2022","journal-title":"Figshare"},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.18637\/jss.v054.i10","article-title":"GLIMMPSE: Online Power Computation for Linear Models with and without a Baseline Covariate.","volume":"54","author":"S Kreidler","year":"2013","journal-title":"J Stat Softw."},{"key":"ref-63","article-title":"Skeletal muscle phenotype of the DE50-MD dog: GLIMMPSE data","author":"J Hildyard","year":"2022","journal-title":"Figshare"},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"51-56","DOI":"10.1016\/j.semcdb.2017.11.005","article-title":"Nuclear positioning in skeletal muscle.","volume":"82","author":"W Roman","year":"2018","journal-title":"Semin Cell Dev Biol."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"33-44","DOI":"10.1016\/j.semcdb.2017.11.020","article-title":"Mef2 and the skeletal muscle differentiation program.","volume":"72","author":"M Taylor","year":"2017","journal-title":"Semin Cell Dev Biol."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"1251-63","DOI":"10.1242\/dev.120.5.1251","article-title":"Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.","volume":"120","author":"D Edmondson","year":"1994","journal-title":"Development."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"11-7","DOI":"10.1111\/j.1365-2990.1982.tb00253.x","article-title":"Muscle fibre size and shape in Duchenne muscular dystrophy.","volume":"8","author":"S Watkins","year":"1982","journal-title":"Neuropathol Appl Neurobiol."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"329-335","DOI":"10.1016\/s0960-8966(97)00058-8","article-title":"Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?","volume":"7","author":"S Wilton","year":"1997","journal-title":"Neuromuscul Disord."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"295-301","DOI":"10.1016\/j.nmd.2010.03.007","article-title":"Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.","volume":"20","author":"V Arechavala-Gomeza","year":"2010","journal-title":"Neuromuscul Disord."},{"key":"ref-70","article-title":"Muscle Biopsy","author":"V Dubowitz","year":"2021"},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"184-90","DOI":"10.1038\/ng0295-184","article-title":"The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced.","volume":"9","author":"C Tennyson","year":"1995","journal-title":"Nat Genet."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"3059-64","DOI":"10.1093\/nar\/24.15.3059","article-title":"Stability of the human dystrophin transcript in muscle.","volume":"24","author":"C Tennyson","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"368-74","DOI":"10.1016\/j.cell.2010.07.022","article-title":"The pioneer round of translation: features and functions.","volume":"142","author":"L Maquat","year":"2010","journal-title":"Cell."},{"key":"ref-74","doi-asserted-by":"publisher","first-page":"43-60","DOI":"10.1007\/s12035-011-8218-9","article-title":"Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene.","volume":"45","author":"R Tadayoni","year":"2012","journal-title":"Mol Neurobiol."},{"key":"ref-75","doi-asserted-by":"publisher","first-page":"5290-9","DOI":"10.1074\/jbc.M411571200","article-title":"Dystrophin Dp71 expression is down-regulated during myogenesis: role of Sp1 and Sp3 on the Dp71 promoter activity.","volume":"280","author":"M de Le\u00f3n","year":"2005","journal-title":"J Biol Chem."},{"key":"ref-76","doi-asserted-by":"publisher","first-page":"17123","DOI":"10.1038\/s41598-020-74157-y","article-title":"Dystrophin Dp71ab is monoclonally expressed in human satellite cells and enhances proliferation of myoblast cells.","volume":"10","author":"M Farea","year":"2020","journal-title":"Sci Rep."},{"key":"ref-77","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/ijms19061546","article-title":"Detection of Dystrophin Dp71 in Human Skeletal Muscle Using an Automated Capillary Western Assay System.","volume":"19","author":"T Kawaguchi","year":"2018","journal-title":"Int J Mol Sci."},{"key":"ref-78","doi-asserted-by":"publisher","first-page":"59-68","DOI":"10.1046\/j.1469-7580.2003.00139.x","article-title":"The formation of skeletal muscle: from somite to limb.","volume":"202","author":"M Buckingham","year":"2003","journal-title":"J Anat."},{"key":"ref-79","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/gb-2004-5-6-226","article-title":"An overview of the basic helix-loop-helix proteins.","volume":"5","author":"S Jones","year":"2004","journal-title":"Genome Biol."},{"key":"ref-80","doi-asserted-by":"publisher","first-page":"1021-1032","DOI":"10.1016\/s0925-4773(03)00178-3","article-title":"mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.","volume":"120","author":"E Dodou","year":"2003","journal-title":"Mech Dev."},{"key":"ref-81","doi-asserted-by":"publisher","first-page":"318-31","DOI":"10.1002\/mus.22094","article-title":"Structure and function of the skeletal muscle extracellular matrix.","volume":"44","author":"A Gillies","year":"2011","journal-title":"Muscle Nerve."},{"key":"ref-82","doi-asserted-by":"publisher","first-page":"311-22","DOI":"10.1007\/s12079-009-0068-0","article-title":"The role of osteopontin in inflammatory processes.","volume":"3","author":"S Lund","year":"2009","journal-title":"J Cell Commun Signal."},{"key":"ref-83","doi-asserted-by":"publisher","first-page":"629-36","DOI":"10.1038\/pr.2015.257","article-title":"Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac\/skeletal muscle function in Duchenne muscular dystrophy.","volume":"79","author":"C Galindo","year":"2016","journal-title":"Pediatr Res."},{"key":"ref-84","doi-asserted-by":"publisher","first-page":"1583-94","DOI":"10.1172\/JCI37662","article-title":"Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta.","volume":"119","author":"S Vetrone","year":"2009","journal-title":"J Clin Invest."},{"key":"ref-85","doi-asserted-by":"publisher","first-page":"291-329","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle.","volume":"82","author":"D Blake","year":"2002","journal-title":"Physiol Rev."},{"key":"ref-86","doi-asserted-by":"publisher","first-page":"19-23","DOI":"10.1016\/j.nmd.2003.09.004","article-title":"A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.","volume":"14","author":"A Weir","year":"2004","journal-title":"Neuromuscul Disord."},{"key":"ref-87","doi-asserted-by":"publisher","first-page":"675-82","DOI":"10.1016\/j.nmd.2004.06.008","article-title":"Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.","volume":"14","author":"A Briguet","year":"2004","journal-title":"Neuromuscul Disord."},{"key":"ref-88","doi-asserted-by":"publisher","first-page":"399-410","DOI":"10.1136\/jnnp.36.3.399","article-title":"Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.","volume":"36","author":"D Dastur","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"ref-89","doi-asserted-by":"publisher","first-page":"S12-8","DOI":"10.1016\/j.numecd.2012.02.002","article-title":"Role of satellite cells in muscle growth and maintenance of muscle mass.","volume":"23 Suppl 1","author":"G Pallafacchina","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"ref-90","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-213X-10-21","article-title":"Dynamics of muscle fibre growth during postnatal mouse development.","volume":"10","author":"R White","year":"2010","journal-title":"BMC Dev Biol."},{"key":"ref-91","doi-asserted-by":"publisher","first-page":"e69194","DOI":"10.1371\/journal.pone.0069194","article-title":"Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice.","volume":"8","author":"Y Echigoya","year":"2013","journal-title":"PLoS One."},{"key":"ref-92","doi-asserted-by":"publisher","first-page":"728-734","DOI":"10.1002\/(sici)1097-4598(199706)20:6<728::aid-mus10>3.0.co;2-q","article-title":"Dystrophin gene transcripts skipping the mdx mutation.","volume":"20","author":"S Wilton","year":"1997","journal-title":"Muscle Nerve."},{"key":"ref-93","doi-asserted-by":"publisher","first-page":"985-96","DOI":"10.1083\/jcb.148.5.985","article-title":"Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion.","volume":"148","author":"Q Lu","year":"2000","journal-title":"J Cell Biol."},{"key":"ref-94","doi-asserted-by":"publisher","first-page":"1115-20","DOI":"10.1002\/mus.880181007","article-title":"Dystrophin-positive fibers in Duchenne dystrophy: origin and correlation to clinical course.","volume":"18","author":"M Fanin","year":"1995","journal-title":"Muscle Nerve."},{"key":"ref-95","doi-asserted-by":"publisher","first-page":"e72147","DOI":"10.1371\/journal.pone.0072147","article-title":"Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related Reappraisal.","volume":"8","author":"S Pigozzo","year":"2013","journal-title":"PLoS One."},{"key":"ref-96","doi-asserted-by":"publisher","first-page":"771-6","DOI":"10.1097\/NEN.0b013e3181e9a34b","article-title":"Targeting fibrosis in Duchenne muscular dystrophy.","volume":"69","author":"L Zhou","year":"2010","journal-title":"J Neuropathol Exp Neurol."},{"key":"ref-97","doi-asserted-by":"publisher","first-page":"965631","DOI":"10.1155\/2014\/965631","article-title":"Understanding the process of fibrosis in Duchenne muscular dystrophy.","volume":"2014","author":"Y Kharraz","year":"2014","journal-title":"Biomed Res Int."},{"key":"ref-98","doi-asserted-by":"publisher","first-page":"152-7","DOI":"10.1001\/archneur.1981.00510030046006","article-title":"Collagen localization in normal and fibrotic human skeletal muscle.","volume":"38","author":"M Foidart","year":"1981","journal-title":"Arch Neurol."},{"key":"ref-99","doi-asserted-by":"publisher","first-page":"415-422","DOI":"10.1097\/WCO.0b013e32834aa3f1","article-title":"Impending therapies for Duchenne muscular dystrophy.","volume":"24","author":"T Partridge","year":"2011","journal-title":"Curr Opin Neurol."},{"key":"ref-100","doi-asserted-by":"publisher","first-page":"342-8","DOI":"10.1016\/j.nmd.2008.02.002","article-title":"Mdx respiratory impairment following fibrosis of the diaphragm.","volume":"18","author":"M Ishizaki","year":"2008","journal-title":"Neuromuscul Disord."},{"key":"ref-101","doi-asserted-by":"publisher","first-page":"943-962","DOI":"10.1113\/JP280656","article-title":"Passive stiffness of fibrotic skeletal muscle in mdx mice relates to collagen architecture.","volume":"599","author":"S Brashear","year":"2021","journal-title":"J Physiol."},{"key":"ref-102","doi-asserted-by":"publisher","first-page":"653-672","DOI":"10.1152\/japplphysiol.00248.2021","article-title":"Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne muscular dystrophy.","volume":"132","author":"R Sahani","year":"2022","journal-title":"J Appl Physiol (1985)."},{"key":"ref-103","doi-asserted-by":"publisher","first-page":"65-72","DOI":"10.1136\/mp.55.2.65","article-title":"Acid phosphatases.","volume":"55","author":"H Bull","year":"2002","journal-title":"Mol Pathol."},{"key":"ref-104","doi-asserted-by":"publisher","first-page":"1447-531","DOI":"10.1152\/physrev.00031.2010","article-title":"Fiber types in mammalian skeletal muscles.","volume":"91","author":"S Schiaffino","year":"2011","journal-title":"Physiol Rev."},{"key":"ref-105","doi-asserted-by":"publisher","first-page":"190-196","DOI":"10.1016\/0022-510x(91)90309-u","article-title":"Muscle regeneration after imposed injury is better in younger than older mdx dystrophic mice.","volume":"104","author":"J Zacharias","year":"1991","journal-title":"J Neurol Sci."},{"key":"ref-106","doi-asserted-by":"publisher","first-page":"307-319","DOI":"10.1093\/hmg\/ddy353","article-title":"Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.","volume":"28","author":"S Guiraud","year":"2019","journal-title":"Hum Mol Genet."},{"key":"ref-107","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41467-022-28666-1","article-title":"A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.","volume":"13","author":"M Dos Santos","year":"2022","journal-title":"Nat Commun."},{"key":"ref-108","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1038\/s41598-022-10341-6","article-title":"Life tables of annual life expectancy and mortality for companion dogs in the United Kingdom.","volume":"12","author":"K Teng","year":"2022","journal-title":"Sci Rep."},{"key":"ref-109","doi-asserted-by":"publisher","first-page":"957014","DOI":"10.1155\/2014\/957014","article-title":"Cellular players in skeletal muscle regeneration.","volume":"2014","author":"L Ceafalan","year":"2014","journal-title":"Biomed Res Int."},{"key":"ref-110","doi-asserted-by":"publisher","first-page":"1027-59","DOI":"10.1002\/cphy.c140068","article-title":"Satellite Cells and Skeletal Muscle Regeneration.","volume":"5","author":"N Dumont","year":"2015","journal-title":"Compr Physiol."},{"key":"ref-111","doi-asserted-by":"publisher","first-page":"2404-12","DOI":"10.1128\/MCB.21.7.2404-2412.2001","article-title":"Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family.","volume":"21","author":"D Bergstrom","year":"2001","journal-title":"Mol Cell Biol."},{"key":"ref-112","doi-asserted-by":"publisher","first-page":"118-26","DOI":"10.1016\/j.stem.2012.03.011","article-title":"Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules.","volume":"11","author":"C Crist","year":"2012","journal-title":"Cell Stem Cell."},{"key":"ref-113","doi-asserted-by":"publisher","first-page":"454-65","DOI":"10.1016\/j.ydbio.2004.05.038","article-title":"Myf5 expression in satellite cells and spindles in adult muscle is controlled by separate genetic elements.","volume":"273","author":"P Zammit","year":"2004","journal-title":"Dev Biol."},{"key":"ref-114","doi-asserted-by":"publisher","first-page":"19-32","DOI":"10.1016\/j.semcdb.2017.11.011","article-title":"Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis.","volume":"72","author":"P Zammit","year":"2017","journal-title":"Semin Cell Dev Biol."},{"key":"ref-115","doi-asserted-by":"publisher","first-page":"139-58","DOI":"10.1083\/jcb.201402079","article-title":"Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy.","volume":"207","author":"S Dadgar","year":"2014","journal-title":"J Cell Biol."},{"key":"ref-116","doi-asserted-by":"publisher","first-page":"8796-801","DOI":"10.1074\/jbc.M709885200","article-title":"Collagen turnover in normal and degenerate human intervertebral discs as determined by the racemization of aspartic acid.","volume":"283","author":"S Sivan","year":"2008","journal-title":"J Biol Chem."},{"key":"ref-117","doi-asserted-by":"publisher","first-page":"1-1","DOI":"10.1096\/fasebj.2020.34.s1.01802","article-title":"Determining Resistance to Protein Turnover in Aged Skeletal Muscle Collagen Using a Novel Stable Isotope Timecourse Approach.","volume":"34","author":"M Lawrence","year":"2020","journal-title":"FASEB J."},{"key":"ref-118","doi-asserted-by":"publisher","first-page":"1169-80","DOI":"10.1091\/mbc.3.10.1169","article-title":"Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces.","volume":"3","author":"L Brown","year":"1992","journal-title":"Mol Biol Cell."},{"key":"ref-119","doi-asserted-by":"publisher","first-page":"453-60","DOI":"10.1111\/j.1365-3083.2007.01908.x","article-title":"Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease.","volume":"65","author":"J Agnholt","year":"2007","journal-title":"Scand J Immunol."},{"key":"ref-120","doi-asserted-by":"publisher","first-page":"463-74","DOI":"10.1016\/j.cytogfr.2006.09.010","article-title":"The regulation and role of osteopontin in malignant transformation and cancer.","volume":"17","author":"M El-Tanani","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref-121","doi-asserted-by":"publisher","first-page":"487-94","DOI":"10.1038\/gene.2009.15","article-title":"Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.","volume":"10","author":"S Kariuki","year":"2009","journal-title":"Genes Immun."},{"key":"ref-122","doi-asserted-by":"publisher","first-page":"241-7","DOI":"10.1080\/03009740801910320","article-title":"Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate.","volume":"37","author":"H Sennels","year":"2008","journal-title":"Scand J Rheumatol."},{"key":"ref-123","doi-asserted-by":"publisher","first-page":"25-32","DOI":"10.1016\/j.jot.2018.01.002","article-title":"Skeletal muscle regeneration is modulated by inflammation.","volume":"13","author":"W Yang","year":"2018","journal-title":"J Orthop Translat."},{"key":"ref-124","doi-asserted-by":"publisher","first-page":"e1007070","DOI":"10.1371\/journal.pgen.1007070","article-title":"Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury.","volume":"13","author":"M Quattrocelli","year":"2017","journal-title":"PLoS Genet."},{"key":"ref-125","doi-asserted-by":"publisher","first-page":"219-26","DOI":"10.1212\/WNL.0b013e318207afeb","article-title":"SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.","volume":"76","author":"E Pegoraro","year":"2011","journal-title":"Neurology."},{"key":"ref-126","doi-asserted-by":"publisher","first-page":"159-62","DOI":"10.1212\/WNL.0b013e31825f04ea","article-title":"Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.","volume":"79","author":"L Bello","year":"2012","journal-title":"Neurology."},{"key":"ref-127","doi-asserted-by":"publisher","first-page":"684-96","DOI":"10.1002\/ana.24370","article-title":"Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study.","volume":"77","author":"L Bello","year":"2015","journal-title":"Ann Neurol."},{"key":"ref-128","doi-asserted-by":"publisher","first-page":"5723-8","DOI":"10.1073\/pnas.1323842111","article-title":"Microtubule binding distinguishes dystrophin from utrophin.","volume":"111","author":"J Belanto","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-129","first-page":"4-8","article-title":"Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives.","volume":"31","author":"L Beytia Mde","year":"2012","journal-title":"Acta Myol."},{"key":"ref-130","doi-asserted-by":"publisher","first-page":"1172-1182","DOI":"10.1016\/j.bbadis.2018.01.030","article-title":"Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice.","volume":"1864","author":"C Pisani","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"ref-131","doi-asserted-by":"publisher","first-page":"492-499","DOI":"10.1002\/phar.1909","article-title":"Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies.","volume":"37","author":"A Reinig","year":"2017","journal-title":"Pharmacotherapy."},{"key":"ref-132","doi-asserted-by":"publisher","first-page":"12575","DOI":"10.1038\/s41598-017-12981-5","article-title":"Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy.","volume":"7","author":"N Doorenweerd","year":"2017","journal-title":"Sci Rep."},{"key":"ref-133","doi-asserted-by":"publisher","first-page":"505-10","DOI":"10.1093\/hmg\/1.7.505","article-title":"Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters.","volume":"1","author":"D Gorecki","year":"1992","journal-title":"Hum Mol Genet."},{"key":"ref-134","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/srep02183","article-title":"Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog.","volume":"3","author":"A Nakamura","year":"2013","journal-title":"Sci Rep."},{"key":"ref-135","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13395-020-00239-0","article-title":"X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.","volume":"10","author":"I Barthelemy","year":"2020","journal-title":"Skelet Muscle."},{"key":"ref-136","doi-asserted-by":"publisher","first-page":"69-81","DOI":"10.1016\/0022-510x(88)90206-7","article-title":"Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies.","volume":"88","author":"B Valentine","year":"1988","journal-title":"J Neurol Sci."},{"key":"ref-137","first-page":"145-54","article-title":"Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ.","volume":"24","author":"Y Shimatsu","year":"2005","journal-title":"Acta Myol."},{"key":"ref-138","doi-asserted-by":"publisher","first-page":"412-424","DOI":"10.1002\/(SICI)1097-0185(19991201)256:4<412::AID-AR8>3.0.CO;2-5","article-title":"Neuromuscular organization of the canine tongue.","volume":"256","author":"L Mu","year":"1999","journal-title":"Anat Rec."},{"key":"ref-139","doi-asserted-by":"publisher","first-page":"e0238521","DOI":"10.1371\/journal.pone.0238521","article-title":"Comparison of growth patterns in healthy dogs and dogs in abnormal body condition using growth standards.","volume":"15","author":"C Salt","year":"2020","journal-title":"PLoS One."},{"key":"ref-140","doi-asserted-by":"publisher","first-page":"205-16","DOI":"10.1085\/jgp.10.2.205","article-title":"Human Growth Curve.","volume":"10","author":"C Davenport","year":"1926","journal-title":"J Gen Physiol."},{"key":"ref-141","article-title":"Various. Jackson Laboratory - Mouse body weight chart"},{"key":"ref-142","doi-asserted-by":"publisher","first-page":"S317-S324","DOI":"10.3233\/JND-210683","article-title":"Changes in Myonuclear Number During Postnatal Growth - Implications for AAV Gene Therapy for Muscular Dystrophy.","volume":"8","author":"J Morgan","year":"2021","journal-title":"J Neuromuscul Dis."},{"key":"ref-143","article-title":"Skeletal muscle phenotype of the DE50-MD dog model -project collection.","author":"J Hildyard","year":"2022","journal-title":"Figshare."},{"key":"ref-144","article-title":"Skeletal muscle phenotype of the DE50-MD dog: Arrive checklist.","author":"J Hildyard","year":"2022","journal-title":"Figshare."}],"container-title":["Wellcome Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-238\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-238\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-238\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:50:16Z","timestamp":1731048616000},"score":1,"resource":{"primary":{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-238\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":144,"URL":"https:\/\/doi.org\/10.12688\/wellcomeopenres.18251.1","relation":{"has-review":[{"id-type":"doi","id":"10.21956\/wellcomeopenres.20230.r54134","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.20230.r53296","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.20230.r54134","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.20230.r53296","asserted-by":"object"}]},"ISSN":["2398-502X"],"issn-type":[{"value":"2398-502X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"Indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-238\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/wellcomeopenres.20230.r53296, Alyson A. Fiorillo, Nikki McCormack, Center for Genetic Medicine Research, Children\u2019s Research Institute, Children\u2019s National Hospital, Washington, DC, 30 Nov 2022, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-238\/v1#referee-response-53296","order":0,"name":"referee-response-53296","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/wellcomeopenres.20230.r54134, Andr\u00e9s G. Vidal-Gadea, School of Biological Sciences, Illinois State University, Normal, IL, 07 Feb 2023, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/7-238\/v1#referee-response-54134","order":1,"name":"referee-response-54134","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by Wellcome [101550, <a href=https:\/\/doi.org\/10.35802\/101550>https:\/\/doi.org\/10.35802\/101550<\/a>]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}